COMP <GO>
SLS vs ZYME // FREE CASH FLOW YIELD
SELLAS Life Sciences Group Inc. (NASDAQ) VS. Zymeworks Inc. (NASDAQ) • 15-METRIC TALLY: SLS 3
— ZYME 2
▲ FREE CASH FLOW YIELD LEADER: SLS
LAST: $10.15 (-2.17%) • MKT CAP: $2.05B
fcf-yield
-1.38%
LAST: $28.71 (-0.66%) • MKT CAP: $2.02B
fcf-yield
-1.71%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SLS VS. ZYME)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SLS | ZYME | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -21.80% | -32.20% | +10.40 | SLS | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | -1.38% | -1.71% | +0.33 | SLS | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -60.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 38.90% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 11.85 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 4/9 | -2.00 | ZYME | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 38.7 | 60.4 | -21.69 | ZYME | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.05B | $2.02B | $27.4M | SLS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SLS REV | ZYME REV | SLS GROSS % | ZYME GROSS % | SLS FCF | ZYME FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $106.0M | — | — | -$28.4M | -$34.5M |
| FY 2024 | $0 | $76.3M | — | — | -$35.4M | -$112.0M |
| FY 2023 | $0 | $76.0M | — | — | -$31.4M | -$118.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SLS // BETA —
ZYME // BETA —